Grantham Mayo Van Otterloo & Co. LLC Trims Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Grantham Mayo Van Otterloo & Co. LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,063,470 shares of the medical equipment provider’s stock after selling 433,844 shares during the period. Intuitive Surgical makes up about 1.8% of Grantham Mayo Van Otterloo & Co. LLC’s holdings, making the stock its 21st biggest position. Grantham Mayo Van Otterloo & Co. LLC owned about 0.30% of Intuitive Surgical worth $555,089,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Atala Financial Inc purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. Summit Securities Group LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Barclays increased their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $451.58 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $160.84 billion, a PE ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55. The business’s 50-day moving average is $545.18 and its 200 day moving average is $532.30.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.